Rheinbrohl, Germany

Christoph Schmitz

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 51(Granted Patents)


Location History:

  • Kerken, DE (2005 - 2008)
  • Rheinbrohl, DE (2004 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Christoph Schmitz - Pushing the Boundaries of Technology and Innovation

Introduction:

Throughout his illustrious career, Christoph Schmitz has emerged as a leading figure in the field of technology and innovation. With a passion for pushing the boundaries of what is possible, he has achieved remarkable milestones and received prestigious recognition for his inventive work. As a highly dedicated individual, Christoph's contributions have made a significant impact on various industries and continue to shape the future.

Latest Patents:

Christoph Schmitz has an impressive portfolio of 16 patents, showcasing his ingenuity and expertise. His latest patents demonstrate his focus on developing inventive solutions in the realm of transdermal drug delivery systems.

The first patent, "Frigostable composition for iontophoretic transdermal delivery of a triptan compound," presents a novel approach for the iontophoretic transdermal delivery of triptan compounds. Through this invention, Christoph Schmitz addresses the challenge of stability in cold temperatures and provides an efficient and effective method for drug administration.

His second patent, "Transdermal therapeutic system for administering water-soluble peptides and polypeptides," centers around the controlled release of water-soluble pharmaceutical active ingredients. By combining a solid phase with a liquid phase, Christoph Schmitz creates a transdermal therapeutic system that releases agents in an aqueous solution, offering a promising alternative to traditional administration routes.

Career Highlights:

Christoph Schmitz has garnered well-deserved recognition for his revolutionary work throughout his career. His dedication to innovation has resulted in numerous accolades, highlighting his contributions to technology and advancements in drug delivery systems. His ability to think beyond conventional boundaries has led to breakthrough solutions that improve patient outcomes and enhance the efficiency of pharmaceutical treatments.

Collaborations:

In his pursuit of innovation, Christoph Schmitz has collaborated with esteemed professionals in his field. Notably, he has worked closely with Mohammad Sameti and Andreas Koch, leveraging their complementary expertise to develop groundbreaking solutions. By fostering collaborations, Christoph promotes knowledge exchange and drives multidisciplinary approaches that lead to remarkable advancements.

Conclusion:

Christoph Schmitz's remarkable career is characterized by his unwavering commitment to pushing the boundaries of technology and innovation. With an impressive patent portfolio and a proven track record of success, he continues to drive change and shape the future of various industries. By addressing challenges in drug delivery systems, Christoph Schmitz's contributions have the potential to enhance patient care and transform the healthcare landscape. We eagerly anticipate his future endeavors as he continues to lead the way in innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…